Articles related to STIMULANTS

Although research exists on the impact of CNS stimulants used in pregnancy, only a few small studies have looked at atomoxetine and pregnancy outcomes. This large cohort study of 4.2 million pregnancies ending in live births in northern Europe and the US reviewed nearly 1,000 pregnancies exposed to atomoxetine in the first trimester. Compared with non-exposed pregnancies, there was no observed increase in major congenital abnormalities with atomoxetine use in the first trimester.

Misuse of prescription stimulants was associated with prior year treatment for depression, ADHD, and substance use disorder. Identified risk factors for stimulant misuse include use of prescription drugs in the past month (5.5 times increased risk) and use of illegal drugs in the past month (8 times higher risk).

Teva Pharmaceuticals is the primary supplier of both branded and generic versions of the stimulant, which is approved to treat ADHD and narcolepsy. Teva has cited increased demand, workforce shortages, and manufacturing disruptions due to packaging constraints as reasons for the supply problems.

After reading this article, head over to this quiz to test your understanding of the findings of a triple-blind, crossover study that involved 173 ADHD-diagnosed children between the ages of 7 and 12. Children received daily education in science, social studies, and vocabulary for 25 minutes over the course of two successive sessions.

According to a recent study published in Clinical Toxicology, the authors examined the makeup of 17 brands of OTC supplements in the US, purchased online, that were labeled to include banned and unapproved stimulants, including deterenol, a beta-agonist that has never been approved for use in the US and which the FDA banned from supplements in 2004.